MPP Teams Up With MedinCell For Investigational Malaria Transmission Treatment
Compound Does Not Protect Against Disease But Could Prevent Onward Transmission
Executive Summary
The Medicines Patent Pool has secured a licensing deal with MedinCell for a long-acting injectable ivermectin drug formulation which could be used to prevent ongoing spread of malaria.